Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126473 | SCV000169980 | benign | not specified | 2014-06-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000557165 | SCV000634068 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453452 | SCV002738391 | likely benign | Inborn genetic diseases | 2017-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003430694 | SCV004150904 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | KCNQ2: BP4, BP7 |
Prevention |
RCV004544264 | SCV004759687 | likely benign | KCNQ2-related disorder | 2019-03-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |